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ABSTRACT: Dystonia is a common movement
disorder. A number of monogenic causes have been iden-
tified. However, the majority of dystonia cases are not
explained by single gene defects. Cervical dystonia is one
of the commonest forms without genetic causes identified.
This pilot study aimed to identify large effect-size risk loci
in cervical dystonia. A genomewide association study
(GWAS) was performed. British resident cervical dystonia
patients of European descent were genotyped using the
Illumina-610-Quad. Comparison was made with controls
of European descent from the Wellcome Trust Case Con-
trol Consortium using logistic regression algorithm from
PLINK. SNPs not genotyped by the array were imputed
with 1000 Genomes Project data using the MaCH algo-
rithm and minimac. Postimputation analysis was done with
the mach2dat algorithm using a logistic regression model.
After quality control measures, 212 cases were compared
with 5173 controls. No single SNP passed the genome-
wide significant level of 5 3 1028 in the analysis of geno-
typed SNP in PLINK. Postimputation, there were 5 clusters
of SNPs that had P value <5 3 1026, and the best cluster
of SNPs was found near exon 1 of NALCN, (sodium leak
channel) with P 5 9.76 3 1027. Several potential regions
were found in the GWAS and imputation analysis. The low-
est P value was found in NALCN. Dysfunction of this ion
channel is a plausible cause for dystonia. Further replica-
tion in another cohort is needed to confirm this finding. We
make this data publicly available to encourage further anal-
yses of this disorder. VC 2013 The Authors. Movement
Disorders published by Wiley Periodicals, Inc. on behalf of
International Parkinson and Movement Disorder Society.
Key Words: cervical dystonia; GWAS; imputation;
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Dystonia is a “syndrome of sustained muscle contrac-
tions, frequently causing twisting and repetitive move-
ments or abnormal postures.”1 It is a common movement
disorder with an estimated prevalence of 430 per million
in the Northern England survey.2,3 The Epidemiological
Study of Dystonia in Europe (ESDE) Collaborative Group
showed crude annual prevalence rate of 152 per million
across 8 European countries.4 The real frequency may be
higher as this study might have underestimated the preva-
lence secondary to underascertainment of cases. An Amer-
ican study online survey on cervical dystonia suggested a
prevalence of up to 0.28%.5
Clinical presentation of dystonia is heterogeneous,
from focal involvement such as cervical dystonia to gen-
eralized torsional dystonia. At present, there are over 20
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dystonia loci named, DYT1 to DYT25. Among these,
DYT1, DYT3, DYT5, DYT6, DYT8, DYT10, DYT11,
DYT12, DYT16, DYT18, CIZ1 (DYT23), ANO3
(DYT24), and GNAL (DYT25) have been cloned.6-10
Cervical dystonia is the most common form of dysto-
nia.3,5,11 A recent Dutch study on focal primary torsion
dystonia reported a positive family history in 25% but
only 2.4% had Mendelian inheritance pattern among
their primary torsion dystonia cases.11 Sixty-four per-
cent (64%) of focal dystonia cases in this Dutch study
were cervical dystonia. The majority of cervical dysto-
nia are transmitted in non-Mendelian pattern, which
suggests cervical dystonia is likely a complex disease
rather than monogenic form. Hitherto, there has been
no report of a high-density genomewide association
study (GWAS) to identify the loci associated with non-
Mendelian dystonia. This study was a pilot attempt to
identify any large effect-size loci.
Patients and Methods
Focal cervical dystonia cases were recruited from 2
movement disorders clinics in UK: (1) National Hospital
for Neurology and Neurosurgery, London; and (2) Sal-
ford Royal Foundation Trust, Manchester. Only cases
that remained focal involvement were recruited and most
of them were followed up in Botulinum Toxin Clinic.
Cases were reviewed by movement disorder specialists,
and only presumptive primary cases were recruited, with
secondary causes like Wilson’s disease or other neurode-
generative disease ruled out where clinically appropriate.
Cases suggestive of Mendelian inheritance were excluded.
DYT1 was excluded where necessary. Because of small
sample size, subclassification according to family history
of movement disorders and age of onset was not
attempted. Only cases of assumed European descent
were recruited. All patients gave informed consent to the
study, approved by the respective local ethics committee.
DNA was extracted locally from blood and genotyped in
the University College London Genomics Microarray
Centre, using Illumina Human 610-Quad BeadChip (Illu-
mina, San Diego, CA, USA).
Control data of European descent was drawn from
the Wellcome Trust Case Control Consortium
(WTCCC) data set as previously reported.12 A total of
2930 samples from 1958 Birth Cohort and 2737 sam-
ples from National Blood Services were genotyped in
Illumina 1.2 M Duo array by the Wellcome Trust
Sanger Institute. Quality control measure was per-
formed both before and after merging with the cases
as detailed in the Supporting Materials.
Genotyped data from cervical dystonia cases was
assembled in GenomeStudio (v2011.1) per the manu-
facturer’s suggestion (Illumina). Postassembly quality
control was performed in GenomeStudio and PLINK
(version 1.07).13 In brief, genotyping quality of the
sample and single-nucleotide polymorphisms (SNPs)
were controlled for in GenomeStudio (Illumina). Fur-
ther checking for gender mismatch, sample relatedness
(identity-by-descent, excluding piHat >0.125) (Pi-Hat –
a parameter in PLINK using estimates of pairwise IBD
to find pairs of individuals who are possibly related.),
Hardy-Weinberg equilibrium (excluding P < 13 1024),
allele frequency (excluding minor allele frequency
[MAF] <0.01), nonrandom missingness (missingness-
by-haplotype, excluding P <1 3 1024; missingness-by-
genotype, excluding P <1 3 1024) and population sub-
structure (excluding 6 SD from combined mean of
Northern and Western European ancestry (CEU) and
Toscani in Italia (TSI) in multidimensional scaling
[MDS] component 1 or 2) were performed in PLINK13
(details in Supporting Materials).
The dystonia sample data was merged with the
Wellcome Trust Case Control Consortium (WTCCC),
and association analysis was performed using logistic
regression in the PLINK package.13 Three covariates
were used in the regression: gender and the first 2
components of PLINK MDS analysis to adjust for gen-
der and genetic variation. Because of our relatively
small sample size, we did not perform separate analy-
sis that looked specifically at known loci.
Imputation for autosomal chromosome was performed
with MaCH14 and minimac,15 in chunks of 10 megabases
with 1 megabase overlapping at both ends. Other parame-
ters were as suggested by authors (details in the Support-
ing Materials). Postimputation association was done in
mach2dat16 excluding imputed SNPs with r squared
(RSQR) <0.3 as suggested. SNPs with MAF <0.03 were
not entered into the final analysis. A higher cutoff was
chosen as the small sample size in this study contributed
to false-positive association in SNPs with low MAF.17
Reference for imputation was taken from the 1000
Genomes Project 2010 August release and composed of
283 individuals from the European continental group.18
Further statistical analysis and plotting were done in
R (version 2.11.1).19 Plots of the identified regions
were made with Locus Zoom.20
Results
A total of 233 cases were genotyped and 212 cases
(66 M, 146 F, mean age 60.6 years, SD 10.9 years)
remained after quality control and 494 k SNPs had
MAF >0.01 (exclusion breakdown in Supporting
Tables 1 and 2). The cases were clustered around the
CEU-TSI controls in the MDS plot confirming Euro-
pean descent (Supporting Fig. 1a-c). These were com-
pared with 5173 controls (2609 M, 2564 F) from
WTCCC. Quantile-quantile (QQ) plot did not deviate
from the expected (Supporting Fig. 3) and lambda was
1.02. No single SNP had reached a genomewide sig-
nificant association (defined as P < 5 3 1028). The
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best signal was rs9416795 (P 5 2.00 3 1026), located
in an intergenic region on chromosome 10. This was
followed by rs1338041 on chromosome 13, intron
region of NALCN, coding for sodium leak channel,
nonselective (Fig. 1A, Supporting Table 3).
After imputation and quality controls (RSQR >0.3
and MAF 0.03), there were 5.67 million SNPs avail-
able in chromosomes 1 to 22. These had satisfactory
genomewide coverage, except a few regions, mainly
telomeric and centromeric regions (Manhattan plot,
Fig. 1B). The regions not well covered with GWAS
and imputation are listed in Supporting Table 7. There
were no SNPs with genomewide significance (defined
as P < 5 3 1028). A few clusters of possible associa-
tions (defined as P < 5 3 1026) were found and
shown in the Manhattan plot (Fig. 1B, Table 1).
With imputation, the best signals found clustered
around NALCN with best P value of 9.8 3 1027 in
rs61973742 and 5 more SNPs in the same gene just
short of the best P value. NALCN protein is a sodium
leaking channel. The majority of the associated SNPs
were found in the first intron between the first and sec-
ond exon. The remaining were within a few kilobases
of the 50 region of exon 1 and 50 untranslated region
(UTR) (Fig. 2A, Supporting Table 6). The second clus-
ter with peak P at 3.1 3 1026 was found in
rs67863238, chromosome 11 base position 48,267,856
(hg19). This cluster codes for a number of olfactory
receptors (OR4X1, OR4X2, OR4S1, and OR4B1)
(Fig. 2B, Supporting Table 5).
Remaining imputed SNPs that passed the possible
associations were found on chromosome (Chr) 1
FIG. 1. (A) Manhattan plot of GWAS. (B) Manhattan plot of imputed result. The SNPs with P < 0.001 in the best 2 regions were labeled in pink,
showing clustering of SNPs around the regions. GWAS, genomewide association study; SNP, single-nucleotide polymorphism. [Color figure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
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RGL1, Chr 2 intergenic 30 of KIAA1715, Chr 10
intergenic, and Chr 11 COL4A1. The SNPs and local
plots of these regions are shown in Supporting Table
4 and Supporting Figures 4 and 5.
Discussion
In this cervical dystonia GWAS, no loci reached a
statistically significant association with dystonia. No
common SNPs or loci with large effect size were
found in dystonia. The most crucial limitation was the
small sample size, which was underpowered to detect
loci with a smaller disease effect. Assuming MAF of
0.4, odds ratio 1.3, additive model, and prevalence of
430 per million in dystonia, it would need more than
1800 cases to achieve an 80% power.21 If the odds
ratio was as high as with the Complement Factor H in
macular degeneration,22 the cohort of 212 cases with
same assumptions would have a power of almost
100% to detect the SNP. Hence, we conclude that a
common SNP with large effect-size is unlikely to be
present in idiopathic cervical dystonia, at least in Chr
1 to 22 as shown in Manhattan plot (Fig. 1) and
within the regions that were usually genotyped by
microarray (Supporting Table 7 for uncovered
regions).
The imputation results showed a few clusters of
potential significance. The top hit found in NALCN
region is interesting. Dysfunction of a sodium channel is
a biologically feasible candidate in dystonia. Allelic
mutation of SCN8A in mice can present with dysto-
nia.23 Our group has also recently identified mutations
in anoctamin (ANO3-DYT23), a calcium-gated chloride
channel gene, leading to autosomal dominant craniocer-
vical dystonia.9 This strongly supports an ion channel as
a plausible candidate gene for dystonia. Such channels
are also potentially pharmacologically modifiable.
NALCN protein is a member of 4 3 6 transmembrane
voltage-independent, nonselective, noninactivating ion
channel found in all animals studied and universally
expressed in mouse brain and spinal cord.24 Our UK
Brain Expression Consortium data shows NALCN is
universal expressed in brain25 (Supporting Fig. 3). In
schizophrenia, the associated SNP in NALCN was
rs2044117, located at the last intron.26 The C-terminal
end of the protein is the important site in coupling with
UNC79 and UNC80 proteins.27 This complex senses
calcium level and results in alteration of leaking current
and neuronal excitability, comparable to ANO3 as a
calcium-gated chloride channel. Mice with exon 1
knocked out die from disrupted respiratory neuronal fir-
ing in the brainstem,24 suggesting regions other than the
C-terminal are also critical. Our SNPs were clustered
around the exon 1 both at 50 and within the first intron.
They may not necessarily be the pathogenic variants but
just tagged SNPs. There are a few synonymous and non-
synonymous SNPs found in the exon 1 (rs144447052,
rs145910377, rs74707055, rs76774740, rs75606652,
rs77203309, rs188237867, rs79047578, and rs9557636).
These SNPs are very rare, with MAF well below
0.01 and not included in the imputation and analy-
sis. These may be pathogenic but unidentified rare
pathogenic variants tagged to our SNPs are also
possible.
Local plot of postimputation SNPs (Fig. 2A, Sup-
porting Table 6) showed multiple SNPs with possible
P value identified. This gives support for possible asso-
ciation of this region with cervical dystonia. The best
SNP from imputation (rs61973742) has a low r2 with
the best SNP rs1338041 in GWAS. There is a great
discrepancy of the MAF, 0.062 in rs61973742 and
TABLE 1. Postimputation SNPs with P value <5 3 1026
SNP CHR Position
Major
allele
Frequency
of major
allele RSQR
a
Effect 1 OR SEM
LR chi
square
P value
of LR Symbol
Predicted
function
Splice
distance
rs61973742 13 102083273 A 0.9384 0.8881 1.579 4.848 0.415 23.9755 9.76E-07 NALCN 50 Upstream
rs1338051 13 102062341 G 0.6595 0.9932 20.481 0.618 0.1 22.5497 2.05E-06 NALCN Intronic 6323
rs9518385 13 102060280 A 0.6597 0.9947 20.48 0.618 0.1 22.5411 2.06E-06 NALCN Intronic 8384
rs9518384 13 102059871 C 0.6597 0.9951 20.48 0.619 0.1 22.5246 2.08E-06 NALCN Intronic 8355
rs1338041
b
13 102058862 A 0.6597 0.9955 20.48 0.619 0.1 22.4931 2.11E-06 NALCN Intronic 7346
rs619152
b
13 110939497 G 0.6437 0.9328 20.489 0.614 0.103 22.1724 2.49E-06 COL4A1 Intronic 19794
rs3916908 13 102058054 A 0.6602 0.9949 20.477 0.621 0.1 22.1374 2.54E-06 NALCN Intronic 6538
rs12132318 1 183797688 T 0.9376 0.3209 21.422 0.241 0.28 22.0992 2.59E-06 RGL1 Intronic 19012
rs67863238 11 48267856 G 0.9439 0.8808 1.608 4.994 0.442 21.7354 3.13E-06 OR4X2 30 Downstream
rs1249277 10 28720076 G 0.8497 0.9894 20.574 0.563 0.118 21.5017 3.54E-06 Intergenic
rs1249281 10 28716177 G 0.8505 0.9956 20.572 0.564 0.118 21.3706 3.79E-06 Intergenic
rs9416795
b
10 28709550 G 0.8508 0.9998 20.57 0.565 0.118 21.2877 3.95E-06 Intergenic
rs10930717 2 176742322 G 0.9524 0.9092 20.896 0.408 0.177 21.1596 4.23E-06 KIAA1715 30 Upstream
rs35875350 11 48230490 G 0.9433 0.9333 1.513 4.538 0.421 20.9828 4.63E-06 OR4B1 50 Upstream
aQuality measure of imputation, from 0 to 1, with values <0.3 suggestive of poorly imputed.
bSNP also found in the nonimputed genotype platform.
SNP, single-nucleotide polymorphism; CHR, chromosome; RSQR, r squared (r2); OR, odds ratio; SEM, standard error of the mean; LR, likelihood ratio.
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0.34 in rs1338041. A discrepancy in MAF can lead to
low r2 (VanLiere and Rosenberg28 and Wray29). These
2 SNPs have a jD0j 5 0.88 despite its low r2 (0.05) in
1000 Genomes 378 European population. Alterna-
tively, there may be a few haplotypes in the region
that are pathogenic. GWAS common SNPs tag to 1
haplotype and others discovered through imputation.
The next potential cluster was in Chr 11. It was not
found in the initial GWAS, but multiple SNPs with
borderline P value were identified from imputation
(Supporting Table 5). If replicated, this represents the
power of finding new associations that are not well
tagged by common SNPs and are identified through
haplotypes inferred during imputation. This group of
FIG. 2. (A) Local association plot with LD of NALCN region (Locus Zoom). There is a cluster of imputed SNPs with P value suggesting possible
association. Red arrow is the best GWAS hit (rs1338041) in this region. (B) Local association plot with LD at Chr 11. Tightly linked imputed SNPs
suggest possible association of cervical dystonia with an uncommon haplotype in the region that was not well tagged by common SNPs in GWAS.
LD, linkage disequilibrium; GWAS, genomewide association study; Chr, chromosome; SNP, single-nucleotide polymorphism. [Color figure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
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associations, namely OR4X1, OR4X2, OR4S1, and
OR4B1, is interesting (Fig. 2B). They belong to the
olfactory receptor, family 4, a type of G-protein-
coupled receptors (GPCRs). Olfactory function may
seem unrelated to dystonia. Recently Fuchs et al.10
reported the association of GNAL mutation with pri-
mary torsion dystonia, and the predominant clinical
feature in these patients is cervical dystonia. GNAL,
coding an olfactory G protein [G(olf)] is found highly
expressed in striatum and coupled with the expression
of dopamine D1 receptor (DRD1).30 It is located at
chromosome 18p. 18p-deletion was reported to be
associated with DYT7.31,32 This association was
recently challenged.33 The 4 olfactory genes (OR4X1,
OR4X2, OR4S1, and OR4B1) are universally
expressed in brain and ORB1 is highly expressed in
striatum as well (Allen Brain Atlas34).
The GWAS and imputation association analysis
employed 2 different algorithms. This may lead to
slightly different P values in GWAS and imputation for
the same SNP. The 3 other hits found in GWAS were
located at intergenic at Chr 6 92 Mb, Chr 10 28 Mb, and
Chr 19 29 Mb. The local plots of postimputation SNPs
in these regions are shown in Supporting Figure 4. The
sparse imputed SNPs around Chr 10 suggested that
might be a false-positive result, as were the imputation
finding at Chr 1 183 Mb and Chr 2 176 Mb (Supporting
Figure 4). The extra SNPs found with imputation at Chr
6 92 Mb and Chr 19 29 Mb suggested potential associa-
tion. The P value was lower than the best 2 clusters in
NALCN and OR4X1 and the functional role within an
intergenic region is difficult to predict. Given the recent
findings from ENCODE, intergenic region may still play
a significant function in transcription.35
In summary, we found a plausible association,
though not statistically confirmed, of cervical dystonia
with SNPs in the NALCN region. Replication on
another cohort of cervical dystonia cases would be
essential to confirm the association. As dystonia
GWAS is relatively understudied, we make all these
data publicly available to encourage further analyses
of the problem.
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